Find similar content

Source channel @githubtrending · Post #14859 · Jun 24

#typescript#cli#clustering#concurrency#dependency_injection#effect#error_handling#javascript#observability#opentelemetry#platform#schema#typescript#workflows Effect is a powerful TypeScript framework that helps you build reliable and complex applications by managing side effects like logging, network calls, and database operations in a safe and organized way. It uses a core `Effect` type to describe workflows that are lazy, composable, and type-safe, allowing you to handle errors and dependencies explicitly. The framework is modular, with many packages for AI, CLI tools, distributed computing, SQL databases, and more, making it flexible for various needs. Using Effect improves code quality, concurrency handling, and maintainability, helping you write robust TypeScript apps efficiently[1][2][4][5]. https://github.com/Effect-TS/effect

Hashtags

#typescript #cli #clustering #concurrency #dependency_injection #effect #error_handling #javascript #observability #opentelemetry #platform #schema #workflows

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选

Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

Find similar View

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Hashtags

#hongkong #pharmaceuticals #biotech #innovation #stockmarket #healthcare #drugdevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

Find similar View

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Hashtags

#biotech #funding #cancer #immunedisorders #california #clinicalstage #therapies #investment #healthcare #innovation #pepromenebio #pharmaceuticals #medicalresearch #drugdevelopment